These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

292 related articles for article (PubMed ID: 18685373)

  • 1. Ethical dilemmas in device treatment for advanced heart failure.
    Kirkpatrick JN; Fedson SE; Verdino R
    Curr Opin Support Palliat Care; 2007 Dec; 1(4):267-73. PubMed ID: 18685373
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ethical challenges in advanced heart failure.
    Kini V; Kirkpatrick JN
    Curr Opin Support Palliat Care; 2013 Mar; 7(1):21-8. PubMed ID: 23328735
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ethics of the heart: ethical and policy challenges in the treatment of advanced heart failure.
    Fields AV; Kirkpatrick JN
    Perspect Biol Med; 2012; 55(1):71-80. PubMed ID: 22643717
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Device based treatment of heart failure.
    Patwala AY; Wright DJ
    Postgrad Med J; 2005 May; 81(955):286-91. PubMed ID: 15879039
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Choices: a study of preferences for end-of-life treatments in patients with advanced heart failure.
    MacIver J; Rao V; Delgado DH; Desai N; Ivanov J; Abbey S; Ross HJ
    J Heart Lung Transplant; 2008 Sep; 27(9):1002-7. PubMed ID: 18765193
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Device therapy in the management of congestive heart failure.
    Turer AT; Rao SV
    Cardiol Rev; 2005; 13(3):130-8. PubMed ID: 15831146
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reducing mortality with device therapy in heart failure patients without ventricular arrhythmias.
    Chapa DW; Lee HJ; Kao CW; Friedmann E; Thomas SA; Anderson J; Bardy GH
    Am J Crit Care; 2008 Sep; 17(5):443-52; quiz 453. PubMed ID: 18776000
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Device therapy for the management of advanced heart failure.
    Krishnamani R; DeNofrio D
    Expert Rev Cardiovasc Ther; 2004 Jul; 2(4):573-80. PubMed ID: 15225116
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ethical considerations for discontinuing pacemakers and automatic implantable cardiac defibrillators at the end-of-life.
    Morgenweck CJ
    Curr Opin Anaesthesiol; 2013 Apr; 26(2):171-5. PubMed ID: 23403711
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ethics guidelines for destination therapy.
    Dudzinski DM
    Ann Thorac Surg; 2006 Apr; 81(4):1185-8. PubMed ID: 16564238
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ethical considerations for ventricular assist device support: a 10-point model.
    Petrucci RJ; Benish LA; Carrow BL; Prato L; Hankins SR; Eisen HJ; Entwistle JW
    ASAIO J; 2011; 57(4):268-73. PubMed ID: 21642842
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Deactivating cardiac pacemakers and implantable cardioverter defibrillators in terminally ill patients.
    Beca JP; Rosselot E; Asenjo R; Anguita V; Quevedo R
    Camb Q Healthc Ethics; 2009; 18(3):236-40. PubMed ID: 19460224
    [No Abstract]   [Full Text] [Related]  

  • 13. Ethical issues and palliative care in the cardiovascular intensive care unit.
    Swetz KM; Mansel JK
    Cardiol Clin; 2013 Nov; 31(4):657-68, x. PubMed ID: 24188227
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A device is not a drug.
    Konstam MA; Pina I; Lindenfeld J; Packer M
    J Card Fail; 2003 Jun; 9(3):155-7. PubMed ID: 12815563
    [No Abstract]   [Full Text] [Related]  

  • 15. Device therapy in the treatment of heart failure.
    Nichols N
    Can J Cardiovasc Nurs; 2006; 16(1):28-31. PubMed ID: 16615262
    [No Abstract]   [Full Text] [Related]  

  • 16. Ethical dilemmas of a large national multi-centre study in Australia: time for some consistency.
    Driscoll A; Currey J; Worrall-Carter L; Stewart S
    J Clin Nurs; 2008 Aug; 17(16):2212-20. PubMed ID: 18705740
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Self-care and communication issues at the end of life of recipients of a left-ventricular assist device as destination therapy.
    Ben Gal T; Jaarsma T
    Curr Opin Support Palliat Care; 2013 Mar; 7(1):29-35. PubMed ID: 23314013
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HRS/EHRA Expert Consensus on the Monitoring of Cardiovascular Implantable Electronic Devices (CIEDs): description of techniques, indications, personnel, frequency and ethical considerations: developed in partnership with the Heart Rhythm Society (HRS) and the European Heart Rhythm Association (EHRA); and in collaboration with the American College of Cardiology (ACC), the American Heart Association (AHA), the European Society of Cardiology (ESC), the Heart Failure Association of ESC (HFA), and the Heart Failure Society of America (HFSA). Endorsed by the Heart Rhythm Society, the European Heart Rhythm Association (a registered branch of the ESC), the American College of Cardiology, the American Heart Association.
    Wilkoff BL; Auricchio A; Brugada J; Cowie M; Ellenbogen KA; Gillis AM; Hayes DL; Howlett JG; Kautzner J; Love CJ; Morgan JM; Priori SG; Reynolds DW; Schoenfeld MH; Vardas PE; ; ; ; ; ; ;
    Europace; 2008 Jun; 10(6):707-25. PubMed ID: 18480075
    [No Abstract]   [Full Text] [Related]  

  • 19. Cardiac resynchronization therapy in heart failure patients: an update.
    Jeevanantham V; Daubert JP; Zareba W
    Cardiol J; 2009; 16(3):197-209. PubMed ID: 19437393
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multidisciplinary approach for circulatory support in patients with advanced heart failure.
    El-Menyar AA
    Expert Rev Cardiovasc Ther; 2009 Mar; 7(3):259-62. PubMed ID: 19296762
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.